Anonymous ID: aa7435 Nov. 6, 2025, 8:57 a.m. No.23820901   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>0909 >>0918 >>1063 >>1284 >>1408 >>1548

trump is going to call for the end of the filibuster and blue slip opening up the government

if he does it.

the dems will lose their shit.

โ€”-

The blue slip and filibuster are distinct mechanisms used in the U.S. Senate to influence judicial nominations, each operating under different rules and with varying degrees of public visibility and political consequence. The blue slip is an unwritten tradition where the Senate Judiciary Committee chair sends a light blue form to both senators from a nomineeโ€™s home state, requesting their approval before a nomination proceeds to a hearing or vote.

If either senator withholds or returns a negative blue slip, the nomination typically stalls, effectively granting a single home-state senator the power to block a nominee without requiring cooperation from their party.

This process is conducted privately and often attracts little public attention, though its use can be politically advantageous for the senator, who may be seen as defending their stateโ€™s interests.

 

In contrast, a filibuster is a formal Senate rule that allows a minority of senators to delay or block a vote on a nomination by extending debate, requiring a supermajority of 60 votes to invoke cloture and end debate.

The filibuster for judicial nominations was eliminated in 2013 through the "nuclear option," which lowered the threshold to a simple majority for most judicial and executive branch nominees, though it remains in place for Supreme Court nominations.

Filibusters are inherently more public and politically risky, as they require coordinated effort among more than 40 senators and involve public votes, making them more partisan in nature.

 

While both mechanisms can obstruct judicial confirmations, they differ significantly in their mechanics and impact. The blue slip allows a single senator to block a nominee without public scrutiny, whereas a filibuster requires broad coalition-building and is more transparent.

Critics argue that the blue slip has been used in a partisan manner, particularly by Republican senators to block nominees from their states, especially during the Obama administration, when it was seen as a way to circumvent the end of the filibuster.

Some, including the NAACP, have called for the elimination of both the filibuster and the blue slip practice, citing concerns over minority obstruction and racial justice.

Despite these calls, the blue slip remains in use, with Senate Judiciary Committee chairs like Patrick Leahy affirming its continued application as long as it is not abused.

Anonymous ID: aa7435 Nov. 6, 2025, 9:33 a.m. No.23821064   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

>>23821059

Eat better and less

Ozempic (semaglutide) can cause a range of side effects, from common gastrointestinal issues to serious long-term risks. The most frequent side effects include nausea, vomiting, diarrhea, stomach pain, constipation, and loss of appetite, which typically improve within a few weeks of starting treatment or after a dose increase.

However, some individuals may experience more severe or long-lasting side effects, including pancreatitis, acute kidney injury, gallbladder disease, and vision changes such as diabetic retinopathy.

There is also a potential risk of thyroid tumors, including medullary thyroid carcinoma (MTC), leading to a boxed warning from the FDA; therefore, Ozempic is contraindicated in people with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2).

 

Common side effects: Nausea, vomiting, diarrhea, stomach pain, constipation, bloating, gas, indigestion, heartburn, dizziness, tiredness, low blood sugar (especially when used with other diabetes medications), and decreased appetite.

Serious side effects: Acute pancreatitis (characterized by severe abdominal pain, nausea, vomiting, and fever), gallstones or gallbladder disease (often presenting with upper-right abdominal pain after fatty meals), diabetic retinopathy (with symptoms like blurred vision, floaters, or sudden vision loss), and acute kidney injury, particularly if dehydration occurs due to vomiting or diarrhea.

Long-term or rare side effects: Vision problems, thyroid tumors (with a known risk in animal studies), and potential for symptoms to persist for weeks after discontinuation of the drug.

Demographic differences: Some studies suggest females may experience headaches and vomiting more frequently than males when taking GLP-1 medications like Ozempic.

Physical changes: Rapid weight loss associated with Ozempic may lead to perceived changes in appearance, such as "Ozempic face" (facial volume loss and sagging skin) or "Ozempic feet" (wrinkled or sagging skin on the feet), which may improve over time as skin adapts.

Contraindications: Ozempic should not be used by individuals with type 1 diabetes, a history of pancreatitis, known hypersensitivity to semaglutide, or those who are pregnant or breastfeeding